Skip to main content
. Author manuscript; available in PMC: 2007 Apr 20.
Published in final edited form as: J Clin Oncol. 2005 Oct 20;23(30):7399–7404. doi: 10.1200/JCO.2004.00.9753

Table 1.

Relative Strengths of Comorbidity Data Sources

Data Feature Existing Clinical Trial Data Prospective Cohorts of Cancer Patients Retrospective Chart Review Administrative Data Linked Tumor Registry Administrative Data
Representative data set (reference No.) Meyerhardt et al (20) Prostate Cancer Outcomes Study (25) Adult Comorbidity Evaluation-27 (10) State and other hospital discharge data sets (31,32) SEER-Medicare (33)
Captures severity of illness ++ +++ +++ + ++
Information on comorbidity ++ +++ +++ + +
Complete cancer information ++++ +++ +++ - +++
Captures other patient information (functional status, social support) ++ +++ + +/− +/−
Generalizability + ++ ++ ++++ ++++
Cost + ++++ ++ + +

NOTE. + indicates “least”; ++++ indicates “greatest.”

Abbreviation: SEER, Surveillance, Epidemiology, and End Results.